5_HT in the dorsal raphe nucleus is involved in the effects of 100_Hz electro_acupuncture on the pain_depression dyad in rats

Authors
Y_Y WU, Y_L JIANG, X_F HE, X_Y ZHAO, X_M SHAO, J SUN, Z SHEN, S_Y SHOU, J_J WEI, J_Y YE, S_S YAN, J-Q FANG


Lab
Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

Journal
Experimental and Therapeutic Medicine

Abstract
The pain_depression dyad is becoming widespread in the clinic and is attracting increasing attention. A previous study by our group found that 100_Hz ectro_acupuncture (EA), but not 2_, 50_ and 2/100_Hz EA, was effective against the reserpine_induced pain_depression dyad. This finding is in contrast to the fact that low_frequency EA is commonly used to treat supraspinal_originating diseases. The present study aimed to investigate the mechanism underlying the effects of 100_Hz EA on the pain_depression dyad. Repeated reserpine injection was found to induce allodynia and depressive behaviors in rats. It decreased _hydroxytryptamine (5_HT) levels and immunoreactive expressions in the dorsal raphe nucleus (DRN). 100_Hz EA alleviated the pain_depression dyad and upregulated 5_HT in the DRN of reserpine_injected rats. Intracerebroventricular injection of para_chlorophenylalanine, an inhibitor of 5_HT resynthesis, suppressed the upregulation of 5_HT in the DRN by 100_Hz EA and partially counteracted the analgesic and anti_depressive effects of 100_Hz EA. The present study was the first to demonstrate that 5_HT in the DRN is involved in mediating the analgesic and anti_depressive effects of 100_Hz EA on the pain_depression dyad. This finding provided a scientific basis for high_frequency EA as a potential treatment for the pain_depression dyad.

BIOSEB Instruments Used:
Electronic Von Frey 4 (BIO-EVF4),Electronic Von Frey 5 with embedded camera (BIO-EVF5)

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.